This is the authors' abstract. We don't add key points for this paper.
PML assembles into nuclear domains that have attracted considerable attention from cell and cancer biologists. Upon stress, PML nuclear bodies modulate sumoylation and other post-translational modifications, providing an integrated molecular framework for the multiple roles of PML in apoptosis, senescence, or metabolism. PML is both a sensor and an effector of oxidative stress. Emerging data has demonstrated its key role in promoting therapy response in several hematological malignancies. While these membrane-less nuclear hubs can enforce efficient cancer cell clearance, their downstream pathways deserve better characterization. PML NBs are druggable and their known modulators may have broader clinical utilities than initially thought.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Rérolle et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: